相似文献
1
Sildenafil for enhanced performance at high altitude?
Ann Intern Med. 2004 Aug 3;141(3):233-5. doi: 10.7326/0003-4819-141-3-200408030-00016.
2
Summaries for patients. Sildenafil increases exercise capacity in low-oxygen settings.
Ann Intern Med. 2004 Aug 3;141(3):I12. doi: 10.7326/0003-4819-141-3-200408030-00001.
3
Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial.
Ann Intern Med. 2004 Aug 3;141(3):169-77. doi: 10.7326/0003-4819-141-3-200408030-00005.
4
Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension.
Am J Respir Crit Care Med. 2005 Feb 1;171(3):275-81. doi: 10.1164/rccm.200406-804OC. Epub 2004 Oct 29.
5
Sildenafil citrate therapy for pulmonary arterial hypertension.
N Engl J Med. 2006 Mar 9;354(10):1091-3; author reply 1091-3.
6
Sildenafil in pulmonary hypertension.
Indian Heart J. 2003 May-Jun;55(3):285; author reply 285.
7
Sildenafil citrate therapy for pulmonary arterial hypertension.
N Engl J Med. 2006 Mar 9;354(10):1091-3; author reply 1091-3.
8
[The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma].
Rev Med Interne. 2007 Dec;28 Suppl 4:S273-6. doi: 10.1016/j.revmed.2007.09.012. Epub 2007 Oct 8.
9
[Treatment of pulmonary arterial hypertension: phosphodiesterase-5 inhibitors].
Dtsch Med Wochenschr. 2006 Dec 8;131(49 Suppl 9):S311-4. doi: 10.1055/s-2006-957199.
10
Therapeutic approaches to pulmonary hypertension in hemoglobinopathies: Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathy.
Ann N Y Acad Sci. 2005;1054:471-5. doi: 10.1196/annals.1345.070.
引用本文的文献
1
Hypoxic pulmonary vasoconstriction does not limit maximal exercise capacity in healthy volunteers breathing 12% oxygen at sea level.
Physiol Rep. 2024 Feb;12(4):e15944. doi: 10.14814/phy2.15944.
Zotero 插件